144 related articles for article (PubMed ID: 2894920)
1. Esmolol: safety and efficacy in postoperative cardiothoracic patients with supraventricular tachyarrhythmias.
Schwartz M; Michelson EL; Sawin HS; MacVaugh H
Chest; 1988 Apr; 93(4):705-11. PubMed ID: 2894920
[TBL] [Abstract][Full Text] [Related]
2. Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias.
Gray RJ; Bateman TM; Czer LS; Conklin CM; Matloff JM
J Am Coll Cardiol; 1985 Jun; 5(6):1451-6. PubMed ID: 2860148
[TBL] [Abstract][Full Text] [Related]
3. Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery.
Mooss AN; Wurdeman RL; Mohiuddin SM; Reyes AP; Sugimoto JT; Scott W; Hilleman DE; Seyedroudbari A
Am Heart J; 2000 Jul; 140(1):176-80. PubMed ID: 10874282
[TBL] [Abstract][Full Text] [Related]
4. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter.
Platia EV; Michelson EL; Porterfield JK; Das G
Am J Cardiol; 1989 Apr; 63(13):925-9. PubMed ID: 2564725
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of esmolol (ASL-8052: an ultrashort-acting beta-adrenergic blocking agent) for control of ventricular rate in supraventricular tachycardias.
Byrd RC; Sung RJ; Marks J; Parmley WW
J Am Coll Cardiol; 1984 Feb; 3(2 Pt 1):394-9. PubMed ID: 6141193
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias.
Steinberg JS; Katz RJ; Somberg JC; Keefe D; Laddu AR; Burge J
Am J Cardiol; 1986 Nov; 58(10):1005-8. PubMed ID: 2877563
[TBL] [Abstract][Full Text] [Related]
7. Combined use of esmolol and digoxin in the acute treatment of atrial fibrillation or flutter.
Shettigar UR; Toole JG; Appunn DO
Am Heart J; 1993 Aug; 126(2):368-74. PubMed ID: 8101692
[TBL] [Abstract][Full Text] [Related]
8. A new dosing regimen for esmolol to treat supraventricular tachyarrhythmia in Chinese patients.
Ko WJ; Chu SH
J Am Coll Cardiol; 1994 Feb; 23(2):302-6. PubMed ID: 7905013
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia.
Sung RJ; Blanski L; Kirshenbaum J; MacCosbe P; Turlapaty P; Laddu AR
J Clin Pharmacol; 1986 Mar; 26(S1):A15-A26. PubMed ID: 2870082
[TBL] [Abstract][Full Text] [Related]
10. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
Barbier GH; Shettigar UR; Appunn DO
Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
[TBL] [Abstract][Full Text] [Related]
11. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.
Mooss AN; Hilleman DE; Mohiuddin SM; Hunter CB
Ann Pharmacother; 1994 Jun; 28(6):701-3. PubMed ID: 7919552
[TBL] [Abstract][Full Text] [Related]
12. Microvascular effects of intravenous esmolol in patients with normal cardiac function undergoing postoperative atrial fibrillation: a prospective pilot study in cardiothoracic surgery.
Fornier W; Jacquet-Lagrèze M; Collenot T; Teixeira P; Portran P; Schweizer R; Ovize M; Fellahi JL
Crit Care; 2017 Dec; 21(1):302. PubMed ID: 29233190
[TBL] [Abstract][Full Text] [Related]
13. Esmolol versus diltiazem in atrial fibrillation following coronary artery bypass graft surgery.
Hilleman DE; Reyes AP; Mooss AN; Packard KA
Curr Med Res Opin; 2003; 19(5):376-82. PubMed ID: 13678474
[TBL] [Abstract][Full Text] [Related]
14. [Successful control of rapid heart rate with atrial flutter by intravenous administration of esmolol in a patient after total correction of the tetralogy of Fallot].
Masamune T; Suzuki S; Nonaka A; Imamura M; Abe F
Masui; 2004 Aug; 53(8):918-20. PubMed ID: 15446684
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic activity of esmolol (ASL-8052)--a novel ultra-short acting beta-adrenoreceptor blocking agent.
Klein G; Wirtzfeld A; Alt E; Steck J; Saunders R; Hulse J; Kartzinel R; Lee R; Laddu AR
Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):112-7. PubMed ID: 6142005
[TBL] [Abstract][Full Text] [Related]
16. Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias.
Balser JR; Martinez EA; Winters BD; Perdue PW; Clarke AW; Huang W; Tomaselli GF; Dorman T; Campbell K; Lipsett P; Breslow MJ; Rosenfeld BA
Anesthesiology; 1998 Nov; 89(5):1052-9. PubMed ID: 9821992
[TBL] [Abstract][Full Text] [Related]
17. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol.
Tempe DK; Mulchandani P; Tandon MS; Mehta N; Tomar AS; Banerjee A; Khanna SK
Indian Heart J; 1999; 51(3):294-300. PubMed ID: 10624069
[TBL] [Abstract][Full Text] [Related]
18. Esmolol in the treatment of supraventricular tachyarrhythmias.
Das G; Ferris J
Can J Cardiol; 1988 May; 4(4):177-80. PubMed ID: 2899451
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias. The Esmolol vs Placebo Multicenter Study Group.
Anderson S; Blanski L; Byrd RC; Das G; Engler R; Laddu A; Lee R; Rajfer S; Schroeder J; Steck JD
Am Heart J; 1986 Jan; 111(1):42-8. PubMed ID: 2868645
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of esmolol for unstable angina pectoris.
Wallis DE; Pope C; Littman WJ; Scanlon PJ
Am J Cardiol; 1988 Nov; 62(16):1033-7. PubMed ID: 2903659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]